Problem statement: Answer the multiple-choice question.
Question: Which drug exhibits a 3.586\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
a COCCCN(C(=O)CCSc1ccc(F)cc1)c1c(N)n(Cc2ccccc2)c(=O)[nH]c1=O
b CCCNCc1cc(OCC)c(OCC(=O)Nc2ccccc2)cc1Br
c CC(C)(C(=O)c1ccccc1)/[N+]([O-])=C/c1ccc(F)cc1
Answer: b. CCCNCc1cc(OCC)c(OCC(=O)Nc2ccccc2)cc1Br
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCCNCc1cc(OCC)c(OCC(=O)Nc2ccccc2)cc1Br
CCCNCc1cc(OCC)c(OCC(=O)Nc2ccccc2)cc1Br
2-[5-bromo-2-ethoxy-4-(propylaminomethyl)phenoxy]-N-phenylacetamide